SPL 0.00% 10.5¢ starpharma holdings limited

ADR volume etc, page-4

  1. 870 Posts.
    lightbulb Created with Sketch. 378
    the only reason i raise the time to approval issue is because POTENTIALLY the party interested in licensing this product might want to wait for the approval to come through. But even that I doubt. I think the global deal isn't too far off.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.